MiMedx Group, Inc. (MDXG)
4.50
-0.01
(-0.22%)
USD |
NASDAQ |
Aug 28, 16:00
4.49
-0.01
(-0.22%)
After-Hours: 16:40
MiMedx Group Cash from Operations (Quarterly) : -10.03M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -10.03M |
| March 31, 2026 | 1.879M |
| December 31, 2025 | 24.96M |
| September 30, 2025 | 29.33M |
| June 30, 2025 | 14.42M |
| March 31, 2025 | 5.299M |
| December 31, 2024 | 19.88M |
| September 30, 2024 | 19.62M |
| June 30, 2024 | 21.81M |
| March 31, 2024 | 4.877M |
| December 31, 2023 | 10.26M |
| September 30, 2023 | 12.79M |
| June 30, 2023 | 7.775M |
| March 31, 2023 | -4.048M |
| December 31, 2022 | -5.624M |
| September 30, 2022 | 0.959M |
| June 30, 2022 | -3.005M |
| March 31, 2022 | -10.22M |
| December 31, 2021 | -3.232M |
| September 30, 2021 | 6.33M |
| June 30, 2021 | 1.599M |
| March 31, 2021 | -6.679M |
| December 31, 2020 | -10.27M |
| September 30, 2020 | -4.618M |
| June 30, 2020 | -3.097M |
| Date | Value |
|---|---|
| March 31, 2020 | -12.28M |
| December 31, 2019 | -23.12M |
| September 30, 2019 | -3.16M |
| June 30, 2019 | 2.13M |
| March 31, 2019 | -15.26M |
| December 31, 2018 | 1.534M |
| September 30, 2018 | 3.397M |
| June 30, 2018 | 20.69M |
| March 31, 2018 | 10.18M |
| December 31, 2017 | 20.86M |
| September 30, 2017 | 17.95M |
| June 30, 2017 | 13.48M |
| March 31, 2017 | 10.64M |
| December 31, 2016 | 16.76M |
| September 30, 2016 | 2.80M |
| June 30, 2016 | 7.219M |
| March 31, 2016 | -0.977M |
| December 31, 2015 | 4.356M |
| September 30, 2015 | 7.308M |
| June 30, 2015 | 2.933M |
| March 31, 2015 | 4.21M |
| December 31, 2014 | 8.284M |
| September 30, 2014 | 8.949M |
| June 30, 2014 | 1.179M |
| March 31, 2014 | -1.611M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | -0.684M |
| Perspective Therapeutics, Inc. | -20.65M |
| ABVC BioPharma, Inc. | -0.2444M |
| Enovis Corp. | 75.03M |
| Edwards Lifesciences Corp. | 651.90M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.635M |
| Cash from Financing (Quarterly) | -13.27M |
| Free Cash Flow | 42.33M |
| Free Cash Flow Per Share (Quarterly) | -0.0722 |
| Free Cash Flow to Equity (Quarterly) | -10.28M |
| Free Cash Flow to Firm (Quarterly) | -10.34M |
| Free Cash Flow Yield | 6.31% |